Ironwood Pharmaceuticals IRWD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $40.77M+209% | $0-100% | $40.08M+999% | $23.6M+2,844% | -$37.39M-798% | ||
| $443K-7.5% | $460K-5.2% | $475K-6.3% | $467K-7.7% | $479K-6.6% | ||
| $3.65M-31.0% | $3.82M-16.3% | $3.61M-56.6% | $4.52M-47.2% | $5.29M-36.9% | ||
| $19.2M+2,765% | $0-100% | $27.77M+262% | $14.11M+6.4% | $670K-88.9% | ||
| $59.1M+240% | -$73.62M— | $34.19M— | $46.4M+434% | -$42.12M+26.2% | ||
| -$4.89M-151% | $0+100% | $10.69M— | -$13.84M-592% | $9.66M+177% | ||
| -$6M-1,573% | -$1.09M+52.1% | $248K— | $64K— | $407K-84.4% | ||
| -$219K-217% | $0+100% | $249K-94.4% | $3.67M-36.5% | $187K-84.0% | ||
| $444K+8.6% | $435K+8.2% | $426K+8.4% | $418K+8.6% | $409K+8.2% | ||
| -$621K-8.6% | -$612K-8.9% | -$603K-8.8% | -$584K-8.8% | -$572K-9.4% | ||
| $5.12M-74.3% | $74.58M+390% | $47.58M+381% | —— | $19.95M-55.6% | ||
| —— | $0— | $2K-87.5% | $2K-96.6% | $31K-54.4% | ||
| —— | $0— | -$2K+87.5% | -$2K+96.6% | -$31K+54.4% | ||
| —— | $122K-39.9% | $0— | $88K-88.3% | $6K-99.9% | ||
| —— | $122K+101% | $0+100% | $88K+100% | $6K+100% | ||
| -$106K-1,414% | —— | -$26K0.0% | -$647K-1,169% | -$7K-129% | ||
| $5.02M-74.8% | $75.05M— | $47.56M+375% | —— | $19.92M-32.2% | ||
| —— | $7.58M-6.8% | $7.58M-6.8% | $7.58M-6.8% | $7.58M-6.8% | ||
| —— | $885.75K-57.9% | $885.75K-57.9% | $885.75K-57.9% | $885.75K-57.9% | ||
| $443K-7.5% | $460K-5.2% | $475K-6.3% | $467K-7.7% | $479K-6.6% | ||
| -$1.1M-4.6% | -$274K+90.0% | -$1.17M— | -$1.61M+68.8% | -$1.05M+88.8% | ||
| -$621K-8.6% | -$612K-8.9% | -$603K-8.8% | -$584K-8.8% | -$572K-9.4% | ||
| -$219K-217% | $0+100% | $249K-94.4% | $3.67M-36.5% | $187K-84.0% | ||
| -$121K+14.2% | -$100K— | -$63K— | -$143K-114% | -$141K-370% | ||
| -$6M-1,573% | -$1.09M+52.1% | $248K— | $64K— | $407K-84.4% | ||
| $444K+8.6% | $435K+8.2% | $426K+8.4% | $418K+8.6% | $409K+8.2% | ||
| $419K+0.7% | $418K+0.7% | $418K+19.4% | $416K-24.4% | $416K-29.4% | ||
| —— | $122K-39.9% | $0— | $88K-88.3% | $6K-99.9% | ||
| —— | $885.75K-57.9% | $885.75K-57.9% | $885.75K-57.9% | $885.75K-57.9% | ||
| —— | $74.58M+390% | $47.58M+382% | —— | $19.92M-55.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ironwood Pharmaceuticals generate?
- Ironwood Pharmaceuticals (IRWD) generated $147.2M in operating cash flow over the trailing twelve months.
- Where does Ironwood Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
